TY - JOUR
T1 - Global guideline for the diagnosis and management of the endemic mycoses
T2 - an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology
AU - Thompson, George R.
AU - Le, Thuy
AU - Chindamporn, Ariya
AU - Kauffman, Carol A.
AU - Alastruey-Izquierdo, Ana
AU - Ampel, Neil M.
AU - Andes, David R.
AU - Armstrong-James, Darius
AU - Ayanlowo, Olusola
AU - Baddley, John W.
AU - Barker, Bridget M.
AU - Lopes Bezerra, Leila
AU - Buitrago, Maria J.
AU - Chamani-Tabriz, Leili
AU - Chan, Jasper F.W.
AU - Chayakulkeeree, Methee
AU - Cornely, Oliver A.
AU - Cunwei, Cao
AU - Gangneux, Jean Pierre
AU - Govender, Nelesh P.
AU - Hagen, Ferry
AU - Hedayati, Mohammad T.
AU - Hohl, Tobias M.
AU - Jouvion, Grégory
AU - Kenyon, Chris
AU - Kibbler, Christopher C.
AU - Klimko, Nikolai
AU - Kong, David C.M.
AU - Krause, Robert
AU - Lee Lee, Low
AU - Meintjes, Graeme
AU - Miceli, Marisa H.
AU - Rath, Peter Michael
AU - Spec, Andrej
AU - Queiroz-Telles, Flavio
AU - Variava, Ebrahim
AU - Verweij, Paul E.
AU - Schwartz, Ilan S.
AU - Pasqualotto, Alessandro C.
N1 - Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2021/12
Y1 - 2021/12
N2 - The global burden of the endemic mycoses (blastomycosis, coccidioidomycosis, emergomycosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and talaromycosis) continues to rise yearly and these infectious diseases remain a leading cause of patient morbidity and mortality worldwide. Management of the associated pathogens requires a thorough understanding of the epidemiology, risk factors, diagnostic methods and performance characteristics in different patient populations, and treatment options unique to each infection. Guidance on the management of these infections has the potential to improve prognosis. The recommendations outlined in this Review are part of the “One World, One Guideline” initiative of the European Confederation of Medical Mycology. Experts from 23 countries contributed to the development of these guidelines. The aim of this Review is to provide an up-to-date consensus and practical guidance in clinical decision making, by engaging physicians and scientists involved in various aspects of clinical management.
AB - The global burden of the endemic mycoses (blastomycosis, coccidioidomycosis, emergomycosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and talaromycosis) continues to rise yearly and these infectious diseases remain a leading cause of patient morbidity and mortality worldwide. Management of the associated pathogens requires a thorough understanding of the epidemiology, risk factors, diagnostic methods and performance characteristics in different patient populations, and treatment options unique to each infection. Guidance on the management of these infections has the potential to improve prognosis. The recommendations outlined in this Review are part of the “One World, One Guideline” initiative of the European Confederation of Medical Mycology. Experts from 23 countries contributed to the development of these guidelines. The aim of this Review is to provide an up-to-date consensus and practical guidance in clinical decision making, by engaging physicians and scientists involved in various aspects of clinical management.
UR - https://www.scopus.com/pages/publications/85122487727
U2 - 10.1016/S1473-3099(21)00191-2
DO - 10.1016/S1473-3099(21)00191-2
M3 - Review article
C2 - 34364529
AN - SCOPUS:85122487727
SN - 1473-3099
VL - 21
SP - e364-e374
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 12
ER -